Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.

被引：0
|
作者：
Li, Jieying [1 ]
Song, Kai [1 ]
Feng, Yuanyong [1 ]
Shang, Wei [1 ]
机构：
[1] Univ Affiliat Hosp Qingda, Affiliated Hosp Qingdao, Qingdao, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18001
引用
收藏
页码：E18001 / E18001
页数：1
相关论文
共 50 条
  • [41] Role of Pembrolizumab in recurrent or metastatic head and neck carcinoma
    Pellini, Raul
    Campo, Flaminia
    Sergi, Domenico
    Cappuzzo, Federico
    ORAL ONCOLOGY, 2021, 115
  • [42] Methotrexate and cetuximab for metastatic advanced head and neck squamous cell carcinoma.
    Atassi, Bassel
    Yoo, George H.
    Robinette, Natasha
    Sibai, Khaled
    Sukari, Ammar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
    Hoell, Pascale Alicia
    Elsayad, Khaled
    Berssenbruegge, Hendrik
    Hering, Dominik
    Kittel, Christopher
    Kleinheinz, Johannes
    Bleckmann, Annalen
    Evers, Georg
    Wardelmann, Eva
    Rudack, Claudia
    Eich, Hans Theodor
    ANTICANCER RESEARCH, 2023, 43 (03) : 1255 - 1263
  • [44] Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients
    Fukuda, Naoki
    Yunokawa, Mayu
    Fujiwara, Yu
    Wang, Xiaofei
    Ohmoto, Akihiro
    Hayashi, Naomi
    Urasaki, Tetsuya
    Sato, Yasuyoshi
    Nakano, Kenji
    Ono, Makiko
    Tomomatsu, Junichi
    Mitani, Hiroki
    Takahashi, Shunji
    CANCER REPORTS, 2021, 4 (02)
  • [45] The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Zhang, Xinyi
    Rui, Mengyu
    Lin, Chao
    Li, Zhi
    Wei, Dongliang
    Han, Ruxue
    Ju, Houyu
    Ren, Guoxin
    CANCER MEDICINE, 2023, 12 (03): : 2702 - 2712
  • [46] Safety and efficacy of SNS-301 plus pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN)
    Algazi, Alain Patrick
    Smith, William
    Bruce, Justine Yang
    Shin, Dong Moon
    Gramza, Ann Wild
    Jelinek, Michael J.
    Singh, Jaswinder
    Misiukiewicz, Krzysztof
    Shah, Dhaval
    Campbell, Jean S.
    Pierce, Robert Hamilton
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Chauffert, Bruno
    Zhou, Yuedan
    Medjkoune, Liza
    Ouikene, Abdenour
    Galez, Agnes
    Belkhir, Farid
    Saint-Germain, Pierre
    Youssef, Ali
    Chehimi, Mohamad
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 13 - 20
  • [48] Comparison of treatment costs of pembrolizumab versus nivolumab in head and neck squamous cell carcinoma.
    Yeh, Justin
    Guddati, Achuta Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Biomarkers and response to pembrolizumab (pembro) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
    Chow, Laura Quan Man
    Mehra, Ranee
    Haddad, Robert I.
    Mahipal, Amit
    Weiss, Jared
    Berger, Raanan
    Eder, Joseph Paul
    Burtness, Barbara
    Tahara, Makoto
    Keam, Bhumsuk
    Le, Dung T.
    Muro, Kei
    Geva, Ravit
    Chung, Hyun Cheol
    Lin, Chia-Chi
    Ayers, Mark
    Aurora-Garg, Deepti
    Lunceford, Jared K.
    Cheng, Jonathan D.
    Seiwert, Tanguy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Capecitabine and cisplatin combination chemotherapy as salvage therapy for recurrent unresectable or metastatic squamous cell carcinoma of the head and neck
    Chung, J.
    Cho, G.
    Shin, H.
    Choi, Y.
    Lee, S.
    Lee, B.
    Wang, S.
    Lee, M.
    Sohn, C.
    Yang, Y.
    EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
12345